British model and actress Cara Delevingne has spoken candidly about her past struggles with addiction, revealing that a widely publicised incident at Burning Man in 2022, which saw her appearing disoriented and distressed, was caused by withdrawal from the drug GHB. Delevingne explained that she had been using the substance, known for its dissociative effects, on a daily basis at the height of her drug use.
The images from September 2022 showed Delevingne at Van Nuys Airport in Los Angeles, appearing dishevelled and exhibiting erratic behaviour, including dropping her phone and smoking from a pipe. These photographs sparked widespread concern among her fans and the public about her well-being. At the time, speculation was rife regarding the cause of her state, with many expressing worry for the prominent figure.
GHB, or gamma-hydroxybutyrate, is a central nervous system depressant that can induce feelings of euphoria, disinhibition, and sedation. However, chronic use can lead to significant physical and psychological dependence, with withdrawal symptoms ranging from insomnia and anxiety to tremors, hallucinations, and severe seizures, which can be life-threatening. Delevingne's revelation highlights the severe risks associated with discontinuing such powerful substances without medical supervision.
Delevingne's openness about her addiction and the specific circumstances surrounding the Burning Man incident forms part of a broader narrative she has shared regarding her journey to sobriety. Her public profile has often placed her personal struggles under intense scrutiny, and her decision to address the events directly offers a new perspective on a period of her life that generated considerable media attention.
This disclosure sheds light on the often hidden challenges faced by individuals struggling with substance abuse, particularly those in the public eye. It underscores the complexity of addiction and the severe physical repercussions that can arise from withdrawal, reinforcing the importance of understanding and addressing drug dependency with appropriate support and treatment.